Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

New technetium 99m-labeled brain perfusion imaging agents.

¹Department of Radiology, University of Pennsylvania, Philadelphia 19104.

Seminars in Nuclear Medicine

|April 1, 1990

Summary

New technetium 99m (99mTc) brain perfusion imaging agents show promise for detecting cerebral vascular abnormalities. These agents demonstrate clinical efficacy comparable to iodine 123-labeled agents, though further research is needed.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Differential gene expression profile of CD4+/CD8+ T cells in patients with hepatitis C virus and/or human immunodeficiency virus infection.

Hong Kong medical journal = Xianggang yi xue za zhi·2016

Same author

Decreased expression of H3K27me3 in human ovarian carcinomas correlates with more aggressive tumor behavior and poor patient survival.

Neoplasma·2015

Same author

MiR-29c mediates epithelial-to-mesenchymal transition in human colorectal carcinoma metastasis via PTP4A and GNA13 regulation of β-catenin signaling.

Annals of oncology : official journal of the European Society for Medical Oncology·2014

Same author

Oncogenic miR-20a and miR-106a enhance the invasiveness of human glioma stem cells by directly targeting TIMP-2.

Oncogene·2014

Same author

HGFK1 inhibits bone metastasis in breast cancer through the TAK1/p38 MAPK signaling pathway.

Cancer gene therapy·2012

Same author

Localization of 5-HT1A and 5-HT2A positive cells in the brainstems of control age-matched and Alzheimer individuals.

Age (Dordrecht, Netherlands)·2010

Area of Science:

Radiochemistry
Nuclear Medicine
Neuroimaging

Background:

Development of novel brain perfusion imaging agents is crucial for diagnosing cerebrovascular diseases.
Technetium 99m (99mTc) complexes offer potential due to their favorable imaging characteristics.

Purpose of the Study:

To investigate the structure-activity relationships of three neutral and lipid-soluble 99mTc complexes for brain uptake and retention.
To evaluate the potential of these new 99mTc agents in detecting cerebral vascular abnormalities.

Main Methods:

Synthesis and characterization of three 99mTc complexes: 99mTc-ethylene cysteinate dimer, 99mTc-hexamethyl propylene amine oxime, and 99mTc-boric acid adduct of technetium oxime.
Assessment of brain uptake and retention properties of these complexes.
Comparison of clinical efficacy with existing iodine 123-labeled brain perfusion agents.

Main Results:

Structure-activity relationships of the 99mTc complexes were investigated regarding brain uptake and retention.
The 99mTc agents demonstrated utility in detecting various cerebral vascular abnormalities.
Initial clinical studies indicated efficacy parallel to iodine 123-labeled agents like isopropyliodoamphetamine.

Conclusions:

The investigated 99mTc complexes represent a new class of neutral, lipid-soluble brain perfusion imaging agents.
These agents show potential for clinical application in diagnosing cerebrovascular conditions.
Further elucidation of trapping mechanisms and clinical validation is warranted.

Related Experiment Videos